rilmenidine has been researched along with Huntington Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuddon, P; Fleming, A; Floto, RA; Goldsmith, P; Jahreiss, L; O'Kane, CJ; Pask, D; Rubinsztein, DC; Saiki, S; Sarkar, S; Siddiqi, FH; Ttofi, EK; Williams, A | 1 |
| Barker, RA; Green-Thompson, ZW; Griffin, J; Jones, PS; Lazic, SE; Mason, SL; Pugh, PJ; Rowe, JB; Rubinsztein, DC; Underwood, BR | 1 |
| Lin, F; Qin, ZH | 1 |
| Acevedo-Arozena, A; Brown, SD; Corrochano, S; Menzies, FM; Renna, M; Rose, C; Rubinsztein, DC; Sadiq, O | 1 |
1 review(s) available for rilmenidine and Huntington Disease
| Article | Year |
|---|---|
Degradation of misfolded proteins by autophagy: is it a strategy for Huntington's disease treatment?
Topics: Autophagy; Carbamazepine; Humans; Huntingtin Protein; Huntington Disease; Lithium; Mutant Proteins; Nerve Tissue Proteins; Oxazoles; Peptides; Rilmenidine; Sirolimus; Trehalose; Trinucleotide Repeat Expansion; Valproic Acid | 2013 |
3 other study(ies) available for rilmenidine and Huntington Disease
| Article | Year |
|---|---|
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
Topics: Animals; Autophagy; Calcium Channels, L-Type; Clonidine; Cyclic AMP; Humans; Huntington Disease; Imidazoline Receptors; Minoxidil; Protein Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Type C Phospholipases; Verapamil | 2008 |
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Brain; Female; Humans; Huntington Disease; Longitudinal Studies; Magnetic Resonance Imaging; Male; Metabolomics; Middle Aged; Neuropsychological Tests; Oxazoles; Retrospective Studies; Rilmenidine; Time Factors; Treatment Outcome; Young Adult | 2017 |
Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease.
Topics: Animals; Autophagy; Cells, Cultured; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Oxazoles; Peptides; Rilmenidine; Rotarod Performance Test | 2010 |